Smartleaf Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Smartleaf Asset Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5	Closed	-$107	–	3477
2026 Q1	$107	Hold	5	–	–	﹤0.01%	3393
2025 Q4	$46	Hold	5	–	–	﹤0.01%	3437
2025 Q3	$34	Hold	5	–	–	﹤0.01%	2988
2025 Q2	$32	Sell	5 -19	-79%	-$131	﹤0.01%	2707
2025 Q1	$193	Buy	+24	New	+$259	﹤0.01%	2800
2024 Q3	–	Sell	-19	Closed	-$262	–	2922
2024 Q2	$262	Buy	+19	New	+$278	﹤0.01%	2644

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Smartleaf Asset Management's DAWN Position: Q2 2026 in Review

Smartleaf Asset Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 5 shares — an estimated $107 sold.

Smartleaf Asset Management first reported a position in DAWN in Q2 2024 and held it in 6 quarters. The position peaked at $262 in Q2 2024. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Smartleaf Asset Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Smartleaf Asset Management sold 5 Day One Biopharmaceuticals shares in Q2 2026, an estimated $107.
Smartleaf Asset Management first reported a position in Day One Biopharmaceuticals in Q2 2024 and held it in 6 quarters.
Smartleaf Asset Management's Day One Biopharmaceuticals position peaked at $262 in Q2 2024.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.